Drawing for FFF ENTERPRISES HELPING HEALTHCARE CARE

USPTO serial 99795357

FFF ENTERPRISES HELPING HEALTHCARE CARE

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
STEINPFAD, SARAH E
Law office
TMO LAW OFFICE 120

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with FFF ENTERPRISES HELPING HEALTHCARE CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marjorie Witter Norman

Marjorie Witter Norman Reed Smith LLP1901 Avenue of the Stars, Suite 700Los Angeles, CA 90067United States

Goods and services

ClassDescriptionStatusFirst use
035Supplying pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines to healthcare providers, hospitals, and pharmacies; Distribution of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Consulting services related to procurement, reimbursement, and distribution in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, vaccines, and specialty pharmacy; Management services provided to healthcare providers, hospitals, and pharmacies for controlling inventory of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Procurement services, namely, procurement of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines for others; Wholesale store services for pharmaceuticals, biopharmaceuticals, human blood products, plasma products, medical supplies, and vaccines; Providing information in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Providing tracking services and information concerning tracking of assets in transit, namely, pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Providing information concerning supply chain and patient safety in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Providing information concerning product recalls in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccinesACTIVENov 7, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Oct 14, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 14, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2026DOCKASSIGNED TO EXAMINER—
May 27, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 29, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance